Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Synthesis, characterization and biological application of 5-quinoline 1,3,5-trisubstituted pyrazole based platinum(II) complexes
Miral V.
Lunagariya
a,
Khyati P.
Thakor
a,
Reena R.
Varma
a,
Bhargav N.
Waghela
b,
Chandramani
Pathak
b and
Mohan N.
Patel
*a
aDepartment of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India. E-mail: jeenen@gmail.com; Tel: +912692 226856 218
bDepartment of Cell Biology, School of Biological Sciences and Biotechnology, Indian Institute of Advanced Research, Koba Institutional Area, Gandhinagar-382007, Gujarat, India. Tel: +91 79 30514245
First published on 2nd February 2018
Abstract
Correction for ‘Synthesis, characterization and biological application of 5-quinoline 1,3,5-trisubstituted pyrazole based platinum(II) complexes’ by Miral V. Lunagariya et al., MedChemComm, 2018, DOI: 10.1039/c7md00472a.
The authors regret that ligands L1–L5 are not named correctly in the manuscript. The names are missing ‘4,5-dihydro’ as displayed in the experimental section. The correct names are as follows: 2-chloro-3-(3-(5-chlorothiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)quinoline (L1), 2-chloro-3-(3-(4-methylthiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)quinoline (L2), 3-(3-(5-bromothiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-2-chloroquinoline (L3), 3-(3-(3-bromothiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-2-chloroquinoline (L4) and 2-chloro-3-(1-phenyl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-5-yl)quinoline (L5).
Scheme 1, with corrected name for L1–L5, is shown below.
 | ||
| Scheme 1 | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2018 |